Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal Cancer

被引:3
|
作者
Conces, Madison L. [1 ]
Mahipal, Amit [1 ]
机构
[1] Case Western Reserve Univ, Univ Hosp Seidman Canc Ctr, Cleveland, OH 44106 USA
关键词
rectal cancer; neoadjuvant therapy; chemotherapy; TOTAL MESORECTAL EXCISION; POSTOPERATIVE ADJUVANT CHEMOTHERAPY; COURSE PREOPERATIVE RADIOTHERAPY; CLINICAL COMPLETE RESPONDERS; MEDIAN FOLLOW-UP; QUALITY-OF-LIFE; COLORECTAL-CANCER; INTERNATIONAL WATCH; SEXUAL DYSFUNCTION; RANDOMIZED-TRIAL;
D O I
10.3390/curroncol31010024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Local and metastatic recurrence are primary concerns following the treatment of locally advanced rectal cancer (LARC). Chemoradiation (CRT) can reduce the local recurrence rates and has subsequently moved to the neoadjuvant setting from the adjuvant setting. Pathological complete response (pCR) rates have also been noted to be greater in patients treated with neoadjuvant CRT prior to surgery. The standard approach to treating LARC would often involve CRT followed by surgery and optional adjuvant chemotherapy and remained the treatment paradigm for almost two decades. However, patients were often unable to complete adjuvant chemotherapy due to a decreased tolerance of chemotherapy following surgery, which led to upfront treatment with both CRT and chemotherapy, and total neoadjuvant therapy, or TNT, was created. The efficacy outcomes of local recurrence, disease-free survival, and pCR have improved in patients receiving TNT compared to the standard approach. Additionally, more recent data suggest a possible improvement in overall survival as well. Patients with a complete clinical response following TNT have the opportunity for watch-and-wait surveillance, allowing some patients to undergo organ preservation. Here, we discuss the clinical trials and studies that led to the adoption of TNT as the standard of care for LARC, with the possibility of watch-and-wait surveillance for patients achieving complete responses. We also review the possibility of overtreating some patients with LARC.
引用
收藏
页码:366 / 382
页数:17
相关论文
共 50 条
  • [41] NAR Score validation in TNT (Total Neoadjuvant treatment) for locally advanced rectal cancer
    PERROT ROSENBERG, I. D.
    Solis Campos, J. A.
    Lazcano Alvarez, G.
    Veillon Contreras, G.
    Tudela Staub, B.
    Olivares Gonzalez, J.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1117 - S1117
  • [42] Total neoadjuvant treatment of locally advanced rectal cancer with high risk factors in Slovenia
    Tuta, Mojca
    Boc, Nina
    Brecelj, Erik
    Omejc, Mirko
    Anderluh, Franc
    Ermenc, Ajra Secerov
    Peressutti, Ana Jeromen
    Oblak, Irena
    Krebs, Bojan
    Velenik, Vaneja
    RADIOLOGY AND ONCOLOGY, 2019, 53 (04) : 465 - 472
  • [43] Validation of the Neoadjuvant Rectal Cancer (NAR) Score for Prognostication Following Total Neoadjuvant Therapy (TNT) for Locally Advanced Rectal Cancer.
    Metzger, April
    Abel, Stephen
    Kirichenko, Alexander
    McCormick, James
    Monga, Dulabh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (02): : E33 - E33
  • [44] Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
    Zhu, Shaoyu
    Brodin, N. Patrik
    English, Keara
    Ohri, Nitin
    Chuy, Jennifer W.
    Rajdev, Lakshmi N.
    Narang, Rahul
    Kalnicki, Shalom
    Guha, Chandan
    Garg, Madhur K.
    Kabarriti, Rafi
    ECLINICALMEDICINE, 2019, 16 : 23 - 29
  • [45] Comparison of Standard Neoadjuvant Therapy and Total Neoadjuvant Therapy in Terms of Effectiveness in Patients Diagnosed with Locally Advanced Rectal Cancer
    Bayramgil, Ayberk
    Bilici, Ahmet
    Tatli, Ali Murat
    Kahraman, Seda
    Altintas, Yunus Emre
    Akgul, Fahri
    Aykan, Musa Baris
    Hamdard, Jamshid
    Goksu, Sema Sezgin
    Sendur, Mehmet Ali Nahit
    Selcukbiricik, Fatih
    Olmez, Omer Fatih
    MEDICINA-LITHUANIA, 2025, 61 (02):
  • [46] In favor of total neoadjuvant therapy (TNT) for locally advanced rectal carcinoma
    Arias, F.
    Asin, G.
    Flamarique, S.
    Hernandez, I.
    Suarez, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (05): : 793 - 794
  • [47] In favor of total neoadjuvant therapy (TNT) for locally advanced rectal carcinoma
    F. Arias
    G. Asín
    S. Flamarique
    I. Hernández
    J. Suarez
    Clinical and Translational Oncology, 2020, 22 : 793 - 794
  • [48] Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer
    Noticewala, Sonal S.
    Das, Prajnan
    CANCER JOURNAL, 2024, 30 (04): : 227 - 231
  • [49] Efficacy and safety of total neoadjuvant therapy in locally advanced rectal cancer: a meta-analysis
    Kai Xiong
    Tiantian Bao
    Yibo Cao
    Wenting Hu
    Jia Deng
    Jiang Chen
    Tianbao Xiao
    International Journal of Colorectal Disease, 38
  • [50] Response to total neoadjuvant therapy and survival in patients with early onset locally advanced rectal cancer
    Lumish, M.
    Do, E.
    Gonen, M.
    Yaeger, R.
    Weiser, M.
    Cercek, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S228 - S228